Hannah Joseph Hospital Limited Reports Insider Share Acquisition of 26,000 Equity Shares by Senior Management Personnel

1 min read     Updated on 06 Apr 2026, 03:05 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Hannah Joseph Hospital Limited disclosed that Dr. Natarajan Arunkumar, senior management personnel, acquired 26,000 equity shares worth Rs. 16,19,420 through three on-market transactions on BSE between February and March 2026. His shareholding increased from 60,060 shares (0.26%) to 86,060 shares (0.38%). The company reported this insider trading activity to BSE on April 06, 2026, in compliance with SEBI regulations.

powered bylight_fuzz_icon
37013745

*this image is generated using AI for illustrative purposes only.

Hannah Joseph Hospital Limited has announced that Dr. Natarajan Arunkumar, a designated person and senior management personnel of the company, has acquired 26,000 equity shares through multiple market transactions. The disclosure was made to BSE Limited on April 06, 2026, in compliance with SEBI insider trading regulations.

Share Acquisition Details

Dr. Natarajan Arunkumar completed the share acquisition through three separate transactions conducted over a two-month period. The purchases were executed on the BSE through on-market transactions with a combined value of Rs. 16,19,420.

Transaction Details: Information
Total Shares Acquired: 26,000
Transaction Value: Rs. 16,19,420
Acquisition Period: February 05, 2026 to March 30, 2026
Exchange: BSE
Mode: On Market

Transaction Breakdown

The acquisition was structured across three separate purchase dates, demonstrating a systematic approach to building the equity position.

Date: Shares Acquired:
February 05, 2026: 2,000
March 13, 2026: 14,000
March 30, 2026: 10,000

Shareholding Position

Following the completion of these transactions, Dr. Arunkumar's total shareholding in Hannah Joseph Hospital Limited has increased significantly. His updated position reflects a notable increase in both absolute share count and percentage ownership.

Shareholding Metric: Before Acquisition After Acquisition
Number of Shares: 60,060 86,060
Percentage Holding: 0.26% 0.38%

Regulatory Compliance

The company received the disclosure from Dr. Natarajan Arunkumar on April 01, 2026, pursuant to Regulation 7(2)(a) of the SEBI Insider Trading Regulations. Hannah Joseph Hospital Limited subsequently informed BSE Limited on April 06, 2026, fulfilling its obligations under Regulation 7(2)(b) of the same regulations. The disclosure was submitted in the prescribed Form C format, providing comprehensive details of the transactions including dates, quantities, and transaction values.

Company Information

Hannah Joseph Hospital Limited operates as a healthcare institution specializing in neurosciences, cardiac sciences, orthopaedics, and traumatology. The company is listed on BSE with scrip code 544687 and trades under the symbol HANNAH. The hospital maintains NABH accreditation and operates from its corporate office in Madurai, Tamil Nadu.

Historical Stock Returns for Hannah Joseph Hospital

1 Day5 Days1 Month6 Months1 Year5 Years
-4.32%-10.00%+20.70%+5.49%+5.49%+5.49%

What strategic initiatives or expansion plans might Hannah Joseph Hospital be pursuing that prompted this insider's increased investment confidence?

How will the hospital's specialized focus on neurosciences and cardiac sciences position it against competitors in the evolving Indian healthcare market?

Could this insider buying signal potential acquisition interest or partnership opportunities for Hannah Joseph Hospital in the near term?

like19
dislike

Hannah Joseph Hospital Files Annual Encumbrance Declaration for FY26 Under SEBI Rules

1 min read     Updated on 03 Apr 2026, 02:20 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Hannah Joseph Hospital Limited completed its annual regulatory filing under SEBI SAST Regulation 31(4) for FY26, with promoter Dr. Mosesjoseph Arunkumar declaring no encumbrance on promoter group shares. The filing follows earlier share acquisition activity where the promoter increased his stake to 69.41% through open market purchases.

powered bylight_fuzz_icon
36255544

*this image is generated using AI for illustrative purposes only.

Hannah Joseph Hospital Limited has filed its annual encumbrance declaration for the financial year ended March 31, 2026, under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The declaration confirms that no encumbrance was created on promoter group shares during the fiscal year.

Annual Compliance Declaration

The company's compliance filing presents the following regulatory submission details:

Parameter: Details
Filing Date: April 02, 2026
Regulation: SEBI SAST Regulation 31(4)
Financial Year: Ended March 31, 2026
Declaration Type: Annual Encumbrance Declaration
Filing Authority: Dr. Mosesjoseph Arunkumar
Exchange: BSE Limited
Company Secretary: CS Yuvaraj Saravanan

Previous Share Acquisition Activity

Earlier in the fiscal year, the company had disclosed a substantial share acquisition by its Promoter and Managing Director, Dr. Moses Joseph Arunkumar, under SEBI's SAST Regulations. The transaction involved acquisition of 46,000 equity shares worth Rs. 32,00,041 on March 30, 2026, through open market purchases on BSE Limited.

Updated Shareholding Structure

Following the previous acquisition, the promoter group shareholding structure includes:

Name: Shares Held Percentage
Dr. Moses Joseph Arunkumar: 1,57,54,925 69.41%
Dr. Fenn Kavitha Fenn Arunkumar: 4,32,000 1.90%
Dr. Arunkumar Nalina: 15 0.00%
Mr. Noyel Arunkumar: 15 0.00%
Mr. Daniel Dayanand Fenn: 8,015 0.04%
Mr. James Prabhukumar Moses: 29,430 0.13%
Total Promoter Group: 1,62,24,400 71.48%

Regulatory Compliance Framework

Dr. Mosesjoseph Arunkumar, acting on behalf of all promoter group members and persons acting in concert, confirmed that no encumbrance was created directly or indirectly on equity shares held in Hannah Joseph Hospital Limited during FY26. The declaration was submitted to BSE Limited's Corporate Relation Department with copies distributed to the company's Audit Committee and Company Secretary.

Company Profile

Hannah Joseph Hospital Limited operates as a NABH-accredited healthcare institution specializing in neurosciences, cardiac sciences, orthopaedics, and traumatology. The company maintains its registered office at K.K.Nagar, Madurai, with corporate office at Chinthamani, Madurai. The company's equity share capital stands at Rs. 22,69,83,630 divided into 2,26,98,363 equity shares of Rs. 10.00 each, listed on BSE Limited with scrip code 544687.

Historical Stock Returns for Hannah Joseph Hospital

1 Day5 Days1 Month6 Months1 Year5 Years
-4.32%-10.00%+20.70%+5.49%+5.49%+5.49%

Will Dr. Moses Joseph Arunkumar continue acquiring shares to further consolidate his majority stake beyond the current 69.41%?

How might the concentrated promoter ownership of 71.48% impact the company's ability to raise capital through equity dilution for expansion plans?

What strategic initiatives is Hannah Joseph Hospital planning that could justify the recent Rs. 32 lakh share acquisition by the promoter?

like20
dislike

More News on Hannah Joseph Hospital

1 Year Returns:+5.49%